首页> 外文期刊>Journal of Diabetes and Endocrinology >Antidiabetic and anti- hyperlipidemic effects of ethanolic extract of Dryopteris dilatata leaves
【24h】

Antidiabetic and anti- hyperlipidemic effects of ethanolic extract of Dryopteris dilatata leaves

机译:鳞毛蕨叶乙醇提取物的抗糖尿病和抗高血脂作用

获取原文
           

摘要

The incidence of diabetes mellitus (DM) is increasing globally and it is a major source of concern. This study was undertaken to assess the antidiabetic effect of the ethanolic leaf extract of Dryopteris dilatata (ELEDD).Thirty adult Wistar rats with body weight (BW) of 120-150 g were randomly assigned to groups of five rats each (n=5). Groups 1 served as normal control; Groups 2-6 were diabetic groups; group 2 served as negative control; group 3 received 50 mg/kg of metformin; 4-6 received 200, 400 and 800 mg/kg of ELEDD respectively. The BW and fasting blood glucose level (FBSL) of the rats were monitored weekly. At the end of the experiment, all the rats were anaesthetized with 25% urethane (sigma- Aldrich) intraperitoneally (I.P) and blood samples were collected by cardiac puncture for biochemical analysis. There was an increase in the BW of the metformin treated group and varying doses of ELEDD. It caused 77.00±15.07% decrease in FBSL; 86.94±34.80% and 248.07±20.56% with respect to 400 and 800 mg/kg of ELEDD. There was a significant (p<0.05) increase in the serum total cholesterol (STC), triglycerides (TG) and low density lipoprotein (LDL-C) as well as decrease in high density lipoproteins (HDL-C). Lipid profile groups treated with ELEDD significantly (p<0.05) decreased in a dose dependent manner .This study has shown that DD has hypoglycemic and hypolipidemic effects.
机译:全球糖尿病(DM)的发病率正在增加,这是一个令人关注的主要问题。这项研究旨在评估Dryopteris dilatata(ELEDD)的乙醇叶提取物的抗糖尿病作用。将30只体重(BW)为120-150 g的成年Wistar大鼠随机分为五组,每组5只(n = 5)。 。第1组作为正常对照; 2-6组为糖尿病组;第2组为阴性对照;第3组接受50 mg / kg二甲双胍; 4-6岁分别接受200、400和800 mg / kg的ELEDD。每周监测大鼠的体重和空腹血糖水平(FBSL)。实验结束时,所有大鼠腹膜内(I.P)用25%尿烷(sigma-Aldrich)麻醉,并通过心脏穿刺收集血样进行生化分析。二甲双胍治疗组的体重增加,并且ELEDD剂量不同。导致FBSL下降77.00±15.07%;相对于400和800 mg / kg ELEDD,分别为86.94±34.80%和248.07±20.56%。血清总胆固醇(STC),甘油三酸酯(TG)和低密度脂蛋白(LDL-C)显着增加(p <0.05),而高密度脂蛋白(HDL-C)降低。 ELEDD治疗组的血脂水平显着降低(p <0.05),且呈剂量依赖性。本研究表明DD具有降血糖和降血脂作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号